HPV Vaccine: Protecting Your Child from Cancer
The U.S. Food and Drug Administration approved a human papillomavirus (HPV) vaccine for females aged 9 to 26 and males aged 9 to 21. It protects against the HPV types that most often cause cervical, vaginal, vulvar, and anal cancers.
The HPV vaccine does not substitute for routine cervical cancer screening (Pap and HPV tests), according to recommended screening guidelines. Currently, screening tests for other types of HPV-associated cancers are not recommended.
Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). It ranges in severity from a mild illness, lasting a few weeks (acute), to a serious long-term (chronic) illness that can lead to liver disease or liver cancer. The hepatitis B vaccine is available for all age groups to prevent HBV infection.
- Cancer Vaccines (National Cancer Institute)